Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)
Clinical trial NCT06305286 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06305286
- Sponsor
- University of Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-04
- Primary completion
- 2029-03-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.